MANA Advisors LLC Purchases New Holdings in Masimo Co. (MASI)
MANA Advisors LLC purchased a new stake in Masimo Co. (NASDAQ:MASI) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 2,682 shares of the medical equipment provider’s stock, valued at approximately $227,000.
Other large investors also recently made changes to their positions in the company. USA Mutuals Advisors Inc. acquired a new stake in shares of Masimo in the 4th quarter worth $110,000. SeaCrest Wealth Management LLC acquired a new stake in shares of Masimo in the 4th quarter worth $116,000. Advisors Preferred LLC acquired a new stake in shares of Masimo in the 4th quarter worth $158,000. DekaBank Deutsche Girozentrale boosted its position in shares of Masimo by 78.3% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after purchasing an additional 925 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Masimo by 39.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,820 shares of the medical equipment provider’s stock worth $239,000 after purchasing an additional 802 shares in the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.
A number of analysts have recently weighed in on the company. Barclays assumed coverage on Masimo in a research report on Friday, March 9th. They issued an “overweight” rating and a $97.00 price objective for the company. Zacks Investment Research cut Masimo from a “buy” rating to a “hold” rating in a research report on Monday, March 5th. Piper Jaffray Companies reaffirmed a “hold” rating and set a $91.00 price target on shares of Masimo in a research report on Thursday, March 1st. Finally, BidaskClub raised Masimo from a “sell” rating to a “hold” rating in a research report on Thursday, March 1st. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $101.00.
Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, February 27th. The medical equipment provider reported $0.72 EPS for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.11. Masimo had a return on equity of 22.75% and a net margin of 16.49%. The company had revenue of $225.20 million during the quarter, compared to analysts’ expectations of $201.54 million. During the same quarter in the previous year, the firm posted $0.46 EPS. The firm’s revenue was up 22.9% compared to the same quarter last year. research analysts predict that Masimo Co. will post 2.81 earnings per share for the current year.
In other Masimo news, Director Sanford Fitch sold 2,000 shares of Masimo stock in a transaction dated Thursday, January 25th. The stock was sold at an average price of $90.00, for a total transaction of $180,000.00. Following the completion of the sale, the director now owns 70,249 shares of the company’s stock, valued at approximately $6,322,410. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Yongsam Lee sold 10,000 shares of Masimo stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $92.95, for a total value of $929,500.00. Following the sale, the executive vice president now directly owns 79,000 shares of the company’s stock, valued at approximately $7,343,050. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 24,000 shares of company stock valued at $2,177,340. 13.10% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: “MANA Advisors LLC Purchases New Holdings in Masimo Co. (MASI)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2018/03/14/mana-advisors-llc-purchases-new-holdings-in-masimo-co-masi.html.
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.